Dr. Moshe Tritel holds a Bachelor’s degree in Biochemistry from Harvard University and a Ph.D. in Cell Biology and Genetics from Weill Cornell Graduate School, where his research focused on intracellular HIV capsid assembly. He also completed a postdoctoral fellowship in vaccine immunology at the NIH’s Vaccine Research Center.

Dr. Tritel’s career in patent law is extensive. He began at Pearl Cohen Zedek Latzer Baratz (the firm’s current name) and continued his work at Webb and Associates and JMB Davis Ben-David. He then served as the Director of Intellectual Property at Pluri Biotech and later as the Vice President of Intellectual Property at 1E Therapeutics. Most recently, he contributed his expertise at Weiss & Arons, LLP, a U.S. patent law firm.

Throughout his career, Dr. Tritel has drafted hundreds of patent applications, primarily in the biomedical and pharmaceutical fields. His experience includes prosecuting thousands of patent applications across a diverse range of technologies, conducting competitor IP surveillance, and performing numerous competitive landscape and patentability analyses. He has also been actively involved in European and Israeli oppositions, as well as due diligence analyses.

Dr. Tritel is happily married with six children. He resides in Bet Shemesh, Israel, where he enjoys studying classical Jewish texts and exercising outdoors. He views the establishment of the Tritel Patent firm as the culmination and natural progression of his extensive experience across a broad spectrum of intellectual property matters.